| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |